# Implantation or Injectable Dosage Form New Animal Drugs; Danofloxacin
> **Food and Drug Administration** · Final rule. · Published 2002-12-27 · Effective 2002-12-27 · 67 FR 78972
## Document
- **Document number:** 02-32747
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 67 FR 78972
- **CFR reference:** 21 CFR 522
- **Publication date:** 2002-12-27
- **Effective date:** 2002-12-27
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pfizer, Inc. The NADA provides for the veterinary prescription use of danofloxacin solution in cattle, by subcutaneous injection, for treatment of bovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica and Pasteurella multocida. FDA is also amending the regulations to add the acceptable daily intake for total residues of danofloxacin and tolerances for residues of danofloxacin in edible tissues of cattle.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2002/12/27/02-32747/implantation-or-injectable-dosage-form-new-animal-drugs-danofloxacin)
---
*AI Analytics · CC0 1.0*